Geron Corporation (GERN) vs Immix Biopharma, Inc. (IMMX)
Geron Corporation and Immix Biopharma, Inc. are both Biotechnology companies. Geron Corporation and Immix Biopharma, Inc. are of similar size ($844.3M and $815.9M). Immix Biopharma, Inc. has the higher net margin (0.00% vs −33.1%) and the higher return on invested capital (0.00% vs −89.9%). Across the 13 metrics below, Immix Biopharma, Inc. leads on 9 and Geron Corporation on 4.
Valuation
Profitability
| Metric | GERN | IMMX | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.51% | — | 65.16% |
| Operating margin | (25.31%) | 0.00% | 0.00% |
| Net margin | (33.05%) | 0.00% | 0.00% |
| Free cash flow margin | (56.10%) | 0.00% | 0.00% |
| Return on equity | (28.28%) | (34.18%) | (57.72%) |
| Return on assets | (12.59%) | (31.34%) | (49.22%) |
| Return on invested capital | (89.85%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack